Non-Surgical Rejuvenation Market Overview
Non-Surgical Rejuvenation Market Size is estimated to reach $11.2 billion by 2027. Furthermore, it is poised to grow at a CAGR of 8.2% over the forecast period of 2022-2027. Non-surgical rejuvenation is used to improve the appearance of the face by restoring its structure and rigidity. Aging is the gradual deterioration of macromolecules, cells, tissues, and organs. If any of that damage can be repaired, photorejuvenation is the result. Beauty clinics, hospitals, and full-service spas all provide dermal fillers products. The major factors driving the market’s growth are the growing number of cosmetic treatment procedures, the increasing aging and mid-aged population, and increasing spending on Hyperpigmentation and Blepharoplasty. Non-surgical skin rejuvenation entails a series of injectable treatments that are tailored to specific needs and aesthetic goals. Both neuromodulators like Botox and a variety of dermal fillers like Juvederm and Restylane could be used. As opposed to a facelift surgery, which requires a couple of weeks of recuperation time following the treatment and is thus less favored by today’s generation, a non-surgical rejuvenation procedure offers more time flexibility. Rising affordability and growing awareness of new innovative and less painful techniques are set to further enhance the overall market demand for the Non-Surgical Rejuvenation Market during the forecast period 2022-2027.
Non-Surgical Rejuvenation Market Report Coverage
The report: “Non-Surgical Rejuvenation Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Non-Surgical Rejuvenation Market.
- Geographically, North America held a dominant market share in the year 2021, owing to the presence of key players in the region and photo-rejuvenation advancements.
- The Increasing disposable income of consumers and rising demand for Facial Rejuvenation around the globe continues to fuel the Non-Surgical Rejuvenation industry’s expansion. The market’s growth will also be fuelled by ongoing research, and advancements in the adhesive coating are pushing the Non-Surgical Rejuvenation industry forward during the forecast period 2022-2027. However, the High cost of Non-Surgical Rejuvenation is poised to create hurdles for the Non-Surgical Rejuvenation Market.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Non-Surgical Rejuvenation Market Report.
Non-Surgical Rejuvenation Market based on type can be further segmented into Topical Rejuvenation Products and Dermal Fillers. Dermal Fillers segment held a dominant market share in the year 2021 and is expected to grow at the quickest rate between 2022 and 2027, with a CAGR of 9.7%. Microdermabrasion treatments use a mildly abrasive instrument to gently sand the skin, removing the thicker, uneven outer layer. This type of skin photo-rejuvenation treats light scarring, discoloration, sun damage, and stretch marks. They are injected to make drooping skin or skin wrinkled due to age appear smooth and plump via photo-rejuvenation. Injectable facial fillers, injectable cosmetic fillers, and soft tissue fillers are all terms for the same thing. They’re made of hyaluronic acid derived from animals or the patient’s fat. One of the primary drivers driving the dermal filler market is increased consumer desire for minimally invasive procedures, population expansion in the 30–65 age bracket, and consumer attraction to beauty and wellbeing. The American Society of Plastic Surgeons (ASPS) reported that more than 2.7 million dermal filler treatments were conducted in 2019. Furthermore, Allergan reported a 17 percent rise in unit sales of dermal filler procedures in 2019, which further propels the segment forward.
Non-Surgical Rejuvenation Market Segment Analysis – By End User
Non-Surgical Rejuvenation Market based on end user can be further segmented into Hospitals/Clinics, Dermatological Clinics, and Others. The dermatological Clinics segment held a dominant market share in the year 2021. This is owing to the ease of availability of experienced healthcare workers, increased government funding, and increased private sector investment in the healthcare industry. Road traffic accidents (RTAs) have arisen as a major public health concern that requires a multidisciplinary strategy to address. In countries like India, the rise in RTA injuries and deaths is frightening. The number of deadly and disabling road accidents is increasing every day, posing a serious public health issue for all authorities involved in their prevention. Increased Dermatological Clinics admissions for Dermal Fillers, and Chemical Peels, as well as an increase in the number of hospitals with state-of-the-art facilities and quick development in the field of rejuvenation. Most skin treatments necessitate a series of sessions to achieve outstanding results, and a multi-modality approach is driving the segment growth.
The Hospitals/Clinics segment is anticipated to grow with the fastest CAGR of 9.9% in the forecast period 2022-2027, owing to the advancements in non-surgical treatment. Non-surgical Photorejuvenation is the procedure a doctor uses to help diagnose a person’s medical problem or to measure the severity of the problem. The results of procedures also help a doctor or other health professional to plan the best course of non-surgical rejuvenation. The availability of advanced non-surgical rejuvenation options in hospitals is also increasing the patient’s preference for hospitals which further drives the market growth.
Non-Surgical Rejuvenation Market Segment Analysis – By Geography
Non-Surgical Rejuvenation Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 34% in the year 2021. The availability of a big patient pool, greater acceptance of topical rejuvenation products, dermal fillers, and increased spending on cosmetic procedures in photorejuvenation are all contributing to the Non-Surgical Rejuvenation Market's growth in this region. In 2020, more than 2.6 million cosmetic procedures involving neurotoxins (such as Botox) were performed, of which the maximum was conducted in the U.S. This indicates that the country's market has a bright future. The United States ranks #1 in the world in terms of non-surgical procedures performed, as per the International Society of Aesthetic Plastic Surgery, thereby, driving regional growth.
Europe is predicted to be the fastest-growing region during the forecast period 2022- 2027, with a CAGR of 9.1% owing to well-developed health care settings and increasing health awareness levels amongst the people.
Non-Surgical Rejuvenation Market Drivers
Growing Adoption of Minimally Invasive Procedures Is Fueling the Demand For Non-Surgical Rejuvenation Market.
The Non-Surgical Rejuvenation Market is growing due to the rising adoption of minimally invasive procedures and combination therapies. With the developments in Photorejuvenation, many consumers are opting for less invasive and less unpleasant operations. For instance, there were 13.3 million cosmetic minimally invasive procedures performed in the year 2020. Dermal fillers treatments have come a long way from equipment-based procedures, from minimally invasive injectables to non-invasive topical skin treatments, further complementing the growing adoption of facial rejuvenation treatments among patients with specific cosmetic concerns, the most common of which is anti-aging. In 2019, the world’s population of 65 and up totaled 703 million as per WHO. In 2050, the geriatric population is expected to increase to 1.5 billion. The proportion of people aged 65 and up in the global population climbed from 6% in 1990 to 9% in 2019. The long-term effects of therapies with clinically approved goods significantly improve adaptability and patient trust, propelling the Non-Surgical Rejuvenation Industry.
Rising Incidence of Accidents is Accelerating the Industry Expansion.
The market is expected to be driven by an increase in car accidents, burns, and trauma events occurring worldwide. According to the World Health Organization (WHO), over 1,000,000 individuals are severely or moderately burned in India each year. Furthermore, according to the National Center for Biotechnology Information (NCBI), nations like Bulgaria, Finland, the Netherlands, China, Australia, and the United Kingdom reported an increase in burn wounds. According to American Burn Association, more than 400,000 people received treatment for burn injury every year. The demand for minimally invasive cosmetic Photorejuvenation procedures has led to an increase in the growth of cosmetic products. Among baby boomers, especially in developing countries, aesthetic medicine is a growing trend as people consider it a part of normal health treatment owing to their desire to maintain a natural and healthy appearance. Patients not only want to be fit and healthy but also want to minimize the effects of aging, driving the Non-Surgical Rejuvenation Market.
Non-Surgical Rejuvenation Market Challenges
Increasing Pricing Pressure is Limiting the Market’s Development.
The high cost of procedures may dissuade clients from returning, especially in emerging markets, stifling the worldwide Non-Surgical Rejuvenation Market’s growth. As per Journal ‘Bone & Joint Open’ non-surgical treatment costs around $2,197, which varies on the patient's requirement. Furthermore, the market’s expansion will likely be hampered by the lack of payment choices for minimally invasive treatments and procedures in emerging markets.
Non-Surgical Rejuvenation Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Non-Surgical Rejuvenation Market. The top 10- Non-Surgical Rejuvenation Market companies are-
- Merz GmbH & Co. KGaA
- Mentor Worldwide LLC
- Cynosure, Inc.
- Gal derma S/A
- Alma Lasers
- Strax Rejuvenation
- Anika Therapeutics, Inc.
- Contura Ltd
- Fibrocell Science, Inc.
- In April 2021, Cynosure, Inc announced that it acquired MyEllevate at ‘The Aesthetic Meeting 2021’. This helps to expand the company portfolio in minimally invasive facial rejuvenation solutions. The company is aiming to expand with the use of a patented ICELD light-guided suture system.
- In March 2021, Lumenis and Baring Private Equity Asia (BPEA) announced to sell Lumenis Surgical Business to Boston Scientific for a transaction value of $1.07 billion. This includes laser and fibers solutions for minimally-invasive surgical procedures in Urology and ENT. This will help lumens to accelerate investment in R&D and global sales and marketing channels.
- In April 2019, Merz GmbH & Co. KGaA launched Belotero® Revive, a dermal filler product containing a unique combination of hyaluronic acid (HA) and glycerol, designed to improve hydration, elasticity, and firmness of the skin. The company is aiming to address the appearance of fine lines. With this launch, the company managed to attract global customers.
Report Code: HCR 0445
Report Code: HCR 0098
Report Code: HCR 0642
For more Lifesciences and Healthcare Market reports, please click here